Dr. Thomas T Tsai, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Anuradha Gudavalli, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Deeann M Rivera, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Cardiology Department, Lafayette, CO 80026 Phone: 303-338-4545 |
Pamela J Decker, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
Dr. Daniel P Drake, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
Committed to providing the solutions labs need to meet the challenges they face, Beckman Coulter Diagnostics has been ranked among the industry's highest performing Service providers in the clinical diagnostics industry in the 2014 IMV ServiceTrak Executive Summary Report.
Patient engagement is considered a key priority In today's healthcare services, both in the context of improved effectiveness of treatment and information technology.
Actavis plc today announced that it has launched its generic version of AstraZeneca's Pulmicort RESPULES® (budesonide inhalation suspension) 0.25 and 0.5 mg vials following a ruling from the United States District Court for the District of New Jersey that (i) United States Patent No. 7,524,834 is invalid, and (ii) AstraZeneca's request for a permanent injunction is denied.
Circadian Age, Inc. – ‘Working Nights' – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is announcing a new Spanish calendar. The 2010 Working Nights Spanish Calendar offers organizations with Hispanic workers the opportunity to show added concern about the health and safety of this group of employees, by providing them with educational material in their own language, to use at home.
› Verified 3 days ago